NeuroSmart Portable MER system paves way for improved treatments in Parkinson’s disease

Positive outcomes with brain pacemakers & NeuroSmart Portable MER (micro-electrode recording) system have paved the way for improved treatments in Parkinson’s disease. The advanced technology according to neuro experts represents a significant leap in deep brain stimulation (DBS) therapy with advanced target localization capabilities, automatic navigation, and connectivity tools for offering unparalleled precision in brain analysis.

A medical breakthrough, at the Fortis Hospital, Bengaluru which said that it managed to set a new benchmark by becoming the first medical care centre in India to implement the NeuroSmart Portable MER system for the treatment of Parkinson’s disease.

It is gathered that a 68-year-old patient battling Parkinson’s disease and severe comorbidities, showed recovery, underlining the efficacy and transformative potential of this technology. Discharged just five days post-surgery. Dr Raghuram G, additional director, neurosurgery, Fortis Hospital, said that such a significant improvement underscores a new era in the management and treatment of Parkinson’s disease at Fortis.

NeuroSmart Portable MER system allows doctors see how the patient is responding to the treatment in real time, which makes the surgery more accurate. The interactive approach enhances neurophysiological mapping of the target area, ensuring precise localization for deep brain stimulation electrode placement. This sophisticated analysis allows us to discern the precise area for electrode placement, ensuring optimal therapeutic efficacy and minimizing potential side effects for our patients, he added.

According to Dr Guruprasad Hosurkar, additional director neurology, Fortis Hospital, said that DBS had a profound effect on enhancing the quality of life for a patient. By alleviating tremors and reducing stiffness, DBS enabled the patient to lead an independent life, empowering him to regain control and enjoy improved well-being.

Noting that global burden of Parkinson’s disease exceeds 10 million, of which India alone accounts for a substantial 10%, Rajinish Menon, CEO & founder, Sukino Healthcare Solutions said that the increasing incidence of the condition in India, especially among the youth population, is a crucial reason why we needs to step up efforts to develop accessible and effective treatments for Parkinson’s.

Currently, Parkinson’s is incurable. Early detection, along with continuous rehabilitation and holistic, personalised treatment, remains the most practical choice. Although research has uncovered that implanting brain pacemakers presents a long-term management option for Parkinson’s, this avenue is inaccessible due to the high costs involved, he added.

Source : 1

A more affordable, easily available treatment approach is continuum care, with services ranging from medication management to emotional support. This offers lasting effects, such as improvements in physical health and the promotion of neuroplasticity, which are crucial for slowing Parkinson’s-related brain degeneration, said Menon.